Integrated bioinformatics and immunohistochemical analysis reveal that S100A16 is correlated with mutational burden, immune evasion, and expression in gastric adenocarcinoma.
[INTRODUCTION] S100A16, a member of the S100 family of calcium-binding proteins, is involved in the progression of several malignancies.
APA
Zhou E, Wang S, et al. (2026). Integrated bioinformatics and immunohistochemical analysis reveal that S100A16 is correlated with mutational burden, immune evasion, and expression in gastric adenocarcinoma.. International journal of clinical and experimental pathology, 19(2), 80-93. https://doi.org/10.62347/CECR4915
MLA
Zhou E, et al.. "Integrated bioinformatics and immunohistochemical analysis reveal that S100A16 is correlated with mutational burden, immune evasion, and expression in gastric adenocarcinoma.." International journal of clinical and experimental pathology, vol. 19, no. 2, 2026, pp. 80-93.
PMID
41868093
Abstract
[INTRODUCTION] S100A16, a member of the S100 family of calcium-binding proteins, is involved in the progression of several malignancies. However, its specific mechanism of action in gastric cancer is not completely understood. The objective of this study, therefore, was to examine the correlation between the expression of S100A16 and clinicopathological characteristics and to investigate its potential significance in gastric adenocarcinoma.
[METHODS] S100A16 messenger RNA (mRNA) expression in stomach cancer was analyzed using bioinformatics to determine the link(s) between diagnostic utility, prognostic importance, tumor mutational burden (TMB), and immune cell infiltration of S100A16 mRNA in patients with gastric cancer.
[RESULTS] S100A16 mRNA expression was elevated in gastric adenocarcinoma, particularly in samples with microsatellite instability. S100A16 mRNA demonstrated significant diagnostic efficacy for gastric cancer. There was a strong correlation between S100A16 mRNA expression and TMB, and a negative correlation between S100A16 mRNA levels and Tumor Immune Dysfunction and Exclusion (i.e., "TIDE") score. Immunohistochemistry results revealed significant differences in S100A16 expression across groups with various histological differentiation in gastric cancer. There was a positive association between S100A16 and P53 expression in those with gastric cancer.
[CONCLUSIONS] There was significant upregulation of S100A16 in gastric adenocarcinoma, which was associated with the level of differentiation and expression of P53. S100A16 may play a role in gene mutations, microsatellite status, and TMB in gastric adenocarcinomas. In addition, S100A16 may be associated with the ability of gastric adenocarcinoma cells to evade the immune system.
[METHODS] S100A16 messenger RNA (mRNA) expression in stomach cancer was analyzed using bioinformatics to determine the link(s) between diagnostic utility, prognostic importance, tumor mutational burden (TMB), and immune cell infiltration of S100A16 mRNA in patients with gastric cancer.
[RESULTS] S100A16 mRNA expression was elevated in gastric adenocarcinoma, particularly in samples with microsatellite instability. S100A16 mRNA demonstrated significant diagnostic efficacy for gastric cancer. There was a strong correlation between S100A16 mRNA expression and TMB, and a negative correlation between S100A16 mRNA levels and Tumor Immune Dysfunction and Exclusion (i.e., "TIDE") score. Immunohistochemistry results revealed significant differences in S100A16 expression across groups with various histological differentiation in gastric cancer. There was a positive association between S100A16 and P53 expression in those with gastric cancer.
[CONCLUSIONS] There was significant upregulation of S100A16 in gastric adenocarcinoma, which was associated with the level of differentiation and expression of P53. S100A16 may play a role in gene mutations, microsatellite status, and TMB in gastric adenocarcinomas. In addition, S100A16 may be associated with the ability of gastric adenocarcinoma cells to evade the immune system.